Cargando…

A reply to questions raised about FEV(1)Q and bronchodilator responsiveness

The recent ATS/ERS technical standard on pulmonary function test interpretive strategies is based on the available evidence https://bit.ly/3hgQsm1

Detalles Bibliográficos
Autores principales:	Miller, Martin R., Stanojevic, Sanja, Kaminsky, David A., Thompson, Bruce R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849703/ https://www.ncbi.nlm.nih.gov/pubmed/36549704 http://dx.doi.org/10.1183/13993003.02025-2022

Ejemplares similares

Bronchodilator Response of FEV6 and FEV3 as Surrogates of Forced Vital Capacity
por: Mehrparvar, Amir Houshang, et al.
Publicado: (2014)

Responses of FEV(6), FVC, and FET to inhaled bronchodilator in the adult general population
por: Kainu, Annette, et al.
Publicado: (2009)

Bronchodilator response cut-off points and FEV (0.75) reference values for spirometry in preschoolers
por: Burity, Edjane Figueiredo, et al.
Publicado: (2016)

Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV(1)
por: Agbetile, J, et al.
Publicado: (2012)

Diagnostic accuracy of pre-bronchodilator FEV(1)/FEV(6) from microspirometry to detect airflow obstruction in primary care: a randomised cross-sectional study
por: van den Bemt, Lisette, et al.
Publicado: (2014)

In reply: Physical distancing or social distancing: that is the question
por: Prin, Meghan, et al.
Publicado: (2020)

Studies Raise Questions about Pavement Sealers
por: Weinhold, Bob
Publicado: (2012)

Reply to Q. Chu et al
por: Semprini, Jason T., et al.
Publicado: (2021)

Reply to Lao Q and Merke DP
por: Baumgartner-Parzer, Sabina, et al.
Publicado: (2021)

Pausing drugs and spacing vaccines: an open question – Authors' reply
por: Rubbert-Roth, Andrea, et al.
Publicado: (2021)

FEV(1) Minimum Important Difference versus Minimal Detectable Difference? In Search of the Unicorn
por: Crim, Courtney, et al.
Publicado: (2021)

Educating Health Professionals about Drug and Device Promotion: Authors' Reply
por: Mansfield, Peter R, et al.
Publicado: (2007)

Questions about comparative genomics of SARS coronavirus isolates
por: Wood, Lowell
Publicado: (2003)

PFCs and Early Menopause: Association Raises Questions about Causality
por: Konkel, Lindsey
Publicado: (2014)

Real ID campaign raises questions about privacy concerns
por: Keller, Sarah N., et al.
Publicado: (2023)

Authors’ reply for “Considerations about causality in observational studies”
por: Wen, Bo, et al.
Publicado: (2021)

Answer for questions of repeated measurements of variance analysis and distribution test of data — Authors’ reply
por: Wang, Dao Wen, et al.
Publicado: (2022)

More questions than answers to the diagnosis and management of cauda equina syndrome—Authors’ reply
por: Woodfield, Julie, et al.
Publicado: (2023)

COPD exacerbations and patient-reported outcomes according to post-bronchodilator FEV(1) – a post-hoc analysis of pooled data
por: Chai, Chee-Shee, et al.
Publicado: (2023)

“Study on factors associated with post bronchodilator reversibility among patients presenting with dyspnea”
por: Vinod, VG
Publicado: (2023)

Reply to Modesto-Alapont et al.: Breaking Circular Thinking about the Value of Oxygenation
por: Tobin, Martin J.
Publicado: (2020)

Reply to Amirav and Newhouse: PC(20) versus PD(20): Why Change a Scientifically Well-Established and Clinically Relevant Test?
por: Kaminsky, David, et al.
Publicado: (2019)

Reply
por: Miller, Jonathan, et al.
Publicado: (2021)

Measures of bronchodilator response of FEV(1), FVC and SVC in a Swedish general population sample aged 50–64 years, the SCAPIS Pilot Study
por: Torén, K, et al.
Publicado: (2017)

COVACTA trial raises questions about tocilizumab's benefit in COVID-19
por: Furlow, Bryant
Publicado: (2020)

Reply
por: Patel, Yogin, et al.
Publicado: (2020)

Questions That This Monograph Raises
Publicado: (2007)

Questions that this paper raises
por: Bandisode, Madhukar S.
Publicado: (2007)

Authors' Reply
por: Bush, Eliot C, et al.
Publicado: (2006)

In reply: Spinal anesthesia for Cesarean delivery in women with COVID-19 infection: questions regarding the cause of hypotension
por: Chen, Rong, et al.
Publicado: (2020)

Continued confusion about inconclusives and error rates: Reply to Weller and Morris
por: Scurich, Nicholas, et al.
Publicado: (2020)

Raising Money for Hospitals
por: Inch, Frank
Publicado: (1923)

Raising Money for Hospitals
por: Chapman, G. Russell
Publicado: (1923)

Raising Money for Hospitals
por: Fenn, W.
Publicado: (1923)

Relationship between FEV(1 )change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review
por: Westwood, Marie, et al.
Publicado: (2011)

Airway Measurement for Airway Remodeling Defined by Post-Bronchodilator FEV1/FVC in Asthma: Investigation Using Inspiration-Expiration Computed Tomography
por: Chae, Eun Jin, et al.
Publicado: (2011)

Reply to “raised concern”
por: JOHANNING, Eckardt, et al.
Publicado: (2021)

Is chronic obstructive pulmonary disease a protective factor in SARS-CoV-2 infection? The importance of bronchodilator treatment()
por: Boixeda, R., et al.
Publicado: (2020)

Comparison of the variability of the annual rates of change in FEV(1) determined from serial measurements of the pre- versus post-bronchodilator FEV(1) over 5 years in mild to moderate COPD: Results of the lung health study
por: Tashkin, Donald P, et al.
Publicado: (2012)

In reply: Clear plastic drapes for aerosol-generating medical procedures in COVID-19 patients: questions still remain
por: Matava, Clyde T., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3bva5cbs716ohajmtl10l9cto8